Atopic Dermatitis: Update for Pediatricians
Authors:
- Katherine GreyKGKatherine Grey
- Sheilagh MaguinessSMSheilagh Maguiness
- 1 August 2016
- journal article
- review article
- Published by SLACK, Inc. in Pediatric Annals
- Vol. 45 (8) , e280-6
Abstract
Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disorder present in up to 20% of children. Recent advances implicate skin barrier dysfunction as central to disease pathogenesis. Genetic defects in the filaggrin gene, the product of which is important for maintaining the epidermal barrier, are a strong predisposing factor in the development of AD. In addition to reducing identifiable triggers, treatment should focus on the four clinical characteristics of eczema: emollients for dry skin, topical anti-inflammatory agents to reduce inflammation and itch, and strategies to reduce infection/colonization, which can include diluted bleach baths. New studies demonstrate that early emollient application from birth may prevent development of AD.[Pediatr Ann. 2016;45(8):e280–e286.]Keywords
This publication has 30 references indexed in Scilit:
- Topical Calcineurin Inhibitors and Lymphoma Risk: Evidence Update with Implications for Daily PracticeAmerican Journal of Clinical Dermatology, 2013
- Evaluation of the Atrophogenic Potential of Topical Corticosteroids in Pediatric Dermatology PatientsPediatric Dermatology, 2011
- Filaggrin in atopic dermatitisJournal of Allergy and Clinical Immunology, 2009
- Treatment of Staphylococcus aureus Colonization in Atopic Dermatitis Decreases Disease SeverityPediatrics, 2009
- The burden of disease associated with filaggrin mutations: A population-based, longitudinal birth cohort studyJournal of Allergy and Clinical Immunology, 2008
- Importance of genetic factors in the etiology of atopic dermatitis: A twin studyAllergy and Asthma Proceedings, 2007
- Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisNature Genetics, 2006
- Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitizationClinical & Experimental Allergy, 2005
- The Burden of Atopic Dermatitis: Impact on the Patient, Family, and SocietyPediatric Dermatology, 2005
- A novel model of sensitization and oral tolerance to peanut proteinImmunology, 2004